ΛΟΙΠΟΙ ΚΛΑΔΟΙ

PHARMACEUTICAL COMPANIES

Edition 10
Publication Year December, 2019
Country Greece
Price 590.00€

PHARMACEUTICAL COMPANIES

The pharmaceutical sector consists of companies which either manufacture or import pharmaceutical and parapharmaceutical products. More than 100 pharmaceutical companies (manufacturers and importers) are estimated to operate in the Greek market, many of which are members of the Hellenic Association of Pharmaceutical Companies (SFEE) and the Panhellenic Association of Pharmaceutical Industries (PEF). Most importers are subsidiaries of multinational groups.
The value of the domestic production of medicines increased by an average annual rate of 10.7% during the period 2002-2011 while in 2012 it registered a fall of 9.2%. However, the Greek pharmaceutical industry "quickly adapted" to the new conditions of the domestic market (increasing demand for generic medicines, exports, etc.). As a result since 2013 the total value of domestically produced medicines has been increasing.
The overall size of the assessed market increased during the period 2000-2009, by an average annual growth rate of 14.1%. However, the difficult course of the Greek economy in recent years and the successive reductions in drug prices have resulted in a decline in market value from 2010 onwards. However, from 2016 onwards it has been increasing, as a result of the ever-increasing hospital pharmaceutical expenditure and in 2018 it registered a rise of 8.8%.
Approximately 43.2% of the total sales of medicines (in value) regards sales to hospitals.